FTFinancial Times·2hBusiness
score-0.60
Investors Voice Opposition to Potential AstraZeneca Agreement
Original
How AstraZeneca’s $400bn deal unravelled
“Words like 'unravelled' and 'revolted' frame the deal failure as a chaotic collapse driven by investor anger.”